Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=6a9996b8fd5e8e08df425b14a7391736
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=c75bfbba2ee89372a0cb0d7c37db1ff5
News ... Kenner (MedUni Wien, Veterinärmedizinische Universität Wien und Ludwig Boltzmann Institut für Krebsforschung) sowie mit KollegInnen aus Graz, Deutschland und Japan gelang erstmals der experimentelle Nachweis, dass eine Blockade von IL-6 bei SLE im Tiermodell einen signifikanten Heilungseffekt haben kann.Bereits in einer früheren Publikation konnte die Arbeitsgruppe um Lukas Kenner (Pflegerl et al. 2009 in PNAS) zeigen, dass bei Autoimmunerkrankungen wie SLE die Produktion von Interleukin 6 (IL-6) aus Keratinozyten der Haut eine Schlüsselrolle bei der Entstehung und Progression der Erkrankung spielt. Dafür... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=3321&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=fbedb5e988236dfa11c253f56369d9da
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?L=3
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/medicine-science/?L=3
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=4eec7e5e56ced03058efa23e78c6868c
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=f7b8aacc5325df0b91e534c46b12ab37
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/medicine-science/?L=3
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/?L=3
Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2869&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=e5fc2c48e5b9272bc434a4f31c2e5220